Laser photocoagulation for proliferative diabetic retinopathy

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 11, 2014, Pages

  Evans, Jennifer R ^a   Michelessi, Manuele ^b   Virgili, Gianni ^c  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IRCCS FONDAZIONE BIETTI   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BEST CORRECTED VISUAL ACUITY; CLINICAL EFFECTIVENESS; CORRECTED DISTANCE VISUAL ACUITY; DISEASE EXACERBATION; DRIVER LICENCE; HUMAN; LASER COAGULATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROLIFERATIVE DIABETIC RETINOPATHY; QUALITY OF LIFE; RETINA DETACHMENT; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VISUAL IMPAIRMENT; VITREOUS HEMORRHAGE; DIABETIC RETINOPATHY; DISEASE COURSE; META ANALYSIS; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TIME; VISION DISORDERS; VISUAL ACUITY; VITREORETINOPATHY, PROLIFERATIVE; WATCHFUL WAITING;

DIABETIC RETINOPATHY; DISEASE PROGRESSION; HUMANS; LASER COAGULATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TIME FACTORS; VISION DISORDERS; VISUAL ACUITY; VITREORETINOPATHY, PROLIFERATIVE; WATCHFUL WAITING;

EID: 84922218322     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD011234.pub2     Document Type: Review

References (156)

1. Anonymous. Diabetic retinopathy study. Report Number 6. Design, methods, and baseline results. Report Number 7. A modification of the Airlie House classification of diabetic retinopathy. Prepared by the Diabetic Retinopathy. Investigative Ophthalmology and Visual Science 1981;21(1 Pt 2):1-226.
2. Anonymous. Indications for photocoagulation treatment of diabetic retinopathy: Diabetic Retinopathy Study Report no. 14. The Diabetic Retinopathy Study Research Group. International Ophthalmology Clinics 1987;27(4):239-53.
3. Anonymous. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group. Ophthalmology 1981;88(7):583-600.
4. Anonymous. Photocoagulation treatment of proliferative diabetic retinopathy: the second report of diabetic retinopathy study findings. Ophthalmology 1978;85(1):82-106.
5. Anonymous. Report Number 6. Design, methods, and baseline results. Investigative Ophthalmology and Visual Science 1981;21(1 Pt 2):149-226.
6. Blankenship GW. Fifteen-year argon laser and xenon photocoagulation results of Bascom Palmer Eye Institute's patients participating in the diabetic retinopathy study. Ophthalmology 1991;98(2):125-8.
7. Blankenship GW. Fifteen-year argon laser and xenon photocoagulation visual results of Bascom Palmer Eye Institute's patients participating in the Diabetic Retinopathy Study. Transactions of the American Ophthalmological Society 1990;88:179-85.
8. Drummond MF, Davies LM, Ferris FL. Assessing the costs and benefits of medical research: the diabetic retinopathy study. Social Science and Medicine 1992;34(9):973-81.
9. Ederer F, Podgor MJ. Assessing possible late treatment effects in stopping a clinical trial early: a case study. Diabetic Retinopathy Study report No. 9. Controlled Clinical Trials 1984;5(4):373-81.
10. Kaufman SC, Ferris FL 3rd, Seigel DG, Davis MD, DeMets DL. Factors associated with visual outcome after photocoagulation for diabetic retinopathy. Diabetic Retinopathy Study Report #13. Investigative Ophthalmology and Visual Science 1989;30(1):23-8.
11. Kaufman SC, Ferris FL, Swartz M. Intraocular pressure following panretinal photocoagulation for diabetic retinopathy. Diabetic Retinopathy Report No. 11. Archives of Ophthalmology 1987;105(6):807-9.
12. Knatterud GL. Mortality experience in the diabetic retinopathy study. Israel Journal of Medical Sciences 1983;19(4):424-8.
13. Anonymous. Early Treatment Diabetic Retinopathy Study design and baseline patient characteristics. ETDRS report number 7. Ophthalmology 1991;98(5 Suppl):741-56.
14. Anonymous. Early photocoagulation for diabetic retinopathy. ETDRS report number 9. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(5 Suppl):766-85.
15. Anonymous. Effects of aspirin treatment on diabetic retinopathy. ETDRS report number 8. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(5 Suppl):757-65.
16. Anonymous. Focal photocoagulation treatment of diabetic macular edema: Relationship of treatment effect to fluorescein angiographic and other retinal characteristics at baseline: ETDRS Report No. 19. Archives of Ophthalmology 1995;113(9):1144-55.
17. Anonymous. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology 1991;98(5 Suppl):823-33.
18. Chew EY, Ferris FL, Csaky KG, Murphy RP, Agrón E, Thompson DJ, et al. The long-term effects of laser photocoagulation treatment in patients with diabetic retinopathy: the early treatment diabetic retinopathy follow-up study. Ophthalmology 2003;110(9):1683-9.
19. Chew EY, Klein ML, Ferris FL, Remaley NA, Murphy RP, Chantry K, et al. Association of elevated serum lipid levels with retinal hard exudate in diabetic retinopathy. Early Treatment Diabetic Retinopathy Study (ETDRS) Report 22. Archives of Ophthalmology 1996;114(9):1079-84.
20. Chew EY, Klein ML, Murphy RP, Remaley NA, Ferris FL. Effects of aspirin on vitreous/preretinal hemorrhage in patients with diabetes mellitus. Early Treatment Diabetic Retinopathy Study report no. 20. Archives of Ophthalmology 1995;113(1):52-5.
21. Chui L, Salti HI, Cavallerano JD, Stockman ME, Arrigg PG, Shah ST, et al. Fifteen year followup of the ocular and medical status of Early Treatment Diabetic Retinopathy Study (ETDRS) patients enrolled at the Joslin Diabetes Center. Investigative Ophthalmology and Visual Science 2005:ARVO E-abstract 4671.
22. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, et al. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18. Investigative Ophthalmology and Visual Science 1998;39(2):233-52.
23. Ferris F. Early photocoagulation in patients with either type I or type II diabetes. Transactions of the American Ophthalmological Society 1996;94:505-37.
24. Fong DS, Barton FB, Bresnick GH. Impaired color vision associated with diabetic retinopathy: Early Treatment Diabetic Retinopathy Study Report No. 15. American Journal of Ophthalmology 1999;128(5):612-7.
25. Fong DS, Ferris FL, Davis MD, Chew EY. Causes of severe visual loss in the early treatment diabetic retinopathy study: ETDRS report no. 24. Early Treatment Diabetic Retinopathy Study Research Group. American Journal of Ophthalmology 1999;127(2):137-41.
26. Fong DS, Myers FL, Segas PP, Hubbard LM, Davis MD, Ferris FL. Subretinal fibrosis in patients with diabetic retinopathy. Investigative Ophthalmology and Visual Science 1995;36:ARVO E-abstract 3796.
27. Hercules BL, Gayed II, Lucas SB, Jeacock J. Peripheral retinal ablation in the treatment of proliferative diabetic retinopathy: a three-year interim report of a randomised, controlled study using the argon laser. British Journal of Ophthalmology 1977;61(9):555-63.
28. Sato Y. Retinal photocoagulation for diabetic retinopathies. Japanese Journal of Clinical Medicine 2005;63(Suppl 6):256-62.
29. Sato Y, Kojimahara N, Kitano S, Kato S, Ando N, Yamaguchi N, et al. Multicenter randomized clinical trial of retinal photocoagulation for preproliferative diabetic retinopathy. Japanese Journal of Ophthalmology 2012;56(1):52-9.
30. Yassur Y, Pickle LW, Fine SL, Singerman L, Orth DH, Patz A. Optic disc neovascularisation in diabetic retinopathy: II. Natural history and results of photocoagulation treatment. British Journal of Ophthalmology 1980;64(2):77-86.
31. Al-Hussainy S, Dodson P M, Gibson J M. Pain response and follow-up of patients undergoing panretinal laser photocoagulation with reduced exposure times. Eye (London, England) 2008;22:96-9.
32. Al-Hussainy SS, Dodson PM, Gibson JM. Pain response in patients undergoing panretinal photocoagulation by continuos wave Nd-YAG laser. Investigative Ophthalmology and Visual Science. 2002;43:ARVO E-abstract 3459.
33. Atmaca LS, Idil A, Gunduz K. Dye laser treatment in proliferative diabetic retinopathy and maculopathy. Acta Ophthalmologica Scandinavica 1995;73(4):303-7.
34. Bandello F, Brancato R, Trabucchi G, Lattanzio R, Malegori A. Diode versus argon-green laser panretinal photocoagulation in proliferative diabetic retinopathy: a randomized study in 44 eyes with a long follow-up time. Graefe's Archive for Clinical and Experimental Ophthalmology 1993;231(9):491-4.
35. Bandello F, Brancato R, Lattanzio R, Trabucchi G, Azzolini C, Malegori A. Double-frequency Nd:YAG laser vs. argon-green laser in the treatment of proliferative diabetic retinopathy: randomized study with long-term follow-up. Lasers in Surgery and Medicine 1996;19(2):173-6.
36. Bandello F, Brancato R, Menchini U, Virgili G, Lanzetta P, Ferrari E, et al. Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy. Seminars in Ophthalmology 2001;16(1):12-8.
37. Bandello FM, Brancato R, Menchini U, Lanzetta P. Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy (PDR). American Academy of Ophthalmology 1999:240.
38. Bandello F, Lattanzio R, Zucchiatti I, Lanzetta P. Treating diabetic retinopathy: Developments and challenges. Diabetes Management 2012;2:191-8.
39. Beetham WP, Aiello LM, Balodimos MC, Koncz L. Ruby laser photocoagulation of early diabetic neovascular retinopathy. Preliminary report of a long-term controlled study. Archives of Ophthalmology 1970;83(3):261-72.
40. Beetham WP, Aiello LM, Balodimos MC, Koncz L. Ruby-laser photocoagulation of early diabetic neovascular retinopathy: preliminary report of a long-term controlled study. Transactions of the American Ophthalmological Society 1969;67:39-67.
41. Birch-Cox J. Defective colour vision in diabetic retinopathy before and after laser photocoagulation. Modern Problems in Ophthalmology 1978;19:326-9.
42. Blankenship GW. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1988;95(2):170-7.
43. Blankenship GW. A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Transactions of the American Ophthalmological Society 1987;85:176-94.
44. Blankenship GW, Gerke E, Batlle JF. Red krypton and blue-green argon laser diabetic panretinal photocoagulation. Graefe's Archive for Clinical and Experimental Ophthalmology 1989;227(4):364-8.
45. Brancato R, Bandello F, Trabucchi G, Leoni G, Lattanzio R. Argon and diode laser photocoagulation in proliferative diabetic retinopathy: a preliminary report. Lasers and Light in Ophthalmology 1990;3(3):233-7.
46. Brancato R, Bandello F, Trabucchi G, Lattanzio R. Frequency-doubled Nd:YAG laser versus argon-green laser photocoagulation in proliferative diabetic retinopathy: a preliminary report. Lasers and Light in Ophthalmology 1991;4:97-102.
47. Anonymous. Photocoagulation for proliferative diabetic retinopathy: a randomised controlled clinical trial using the xenon-arc. Diabetologia 1984;26(2):109-15.
48. Anonymous. Proliferative diabetic retinopathy: treatment with xenon-arc photocoagulation. Interim report of multicentre randomised controlled trial. British Medical Journal 1977;1(6063):739-41.
49. British Multicentre Study Group. Photocoagulation for diabetic maculopathy. A randomized controlled clinical trial using the xenon arc. British Multicentre Study Group. Diabetes 1983;32(11):1010-6.
50. Cheng H. Multicentre trial of xenon-arc photocoagulation in the treatment of diabetic retinopathy. A randomized controlled study. Transactions of the Opthalmological Society 1975;95:351-7.
51. Cheng H. Response of proliferative diabetic retinopathy to xenon-arc photocoagulation. A multicentre randomized controlled trial. Second interim report. Transactions of the Ophthalmological Societies of the United Kingdom 1976;96(2):224-7.
52. Buckley S, Jenkins L, Benjamin L. Field loss after pan retinal photocoagulation with diode and argon lasers. Documenta Ophthalmologica. Advances in Ophthalmology 1992;82(4):317-22.
53. Canning C, Polkinghorne P, Ariffin A, Gregor Z. Panretinal laser photocoagulation for proliferative diabetic retinopathy: the effect of laser wavelength on macular function. British Journal of Ophthalmology 1991;75(10):608-10.
54. Capoferri C, Bagini M, Chizzoli A, Pece A, Brancato R. Electroretinographic findings in panretinal photocoagulation for diabetic retinopathy. A randomized study with blue-green argon and red krypton lasers. Graefe's Archive for Clinical and Experimental Ophthalmology 1990;228(3):232-6.
55. Chaine G, Zerah I, Coscas G. Panretinal photocoagulation and proliferative diabetic retinopathy. Results of a long-term prospective study (2d report) [Photocoagulation pan-retinienne et retinopathie diabetique proliferante. Resultats d'une etude prospective a long terme (second rapport)]. Bulletin des Societes d'Ophtalmologie de France 1986;86(11):1369-72.
56. Chen Z, Song Y. Functional and structural changes after pattern scanning laser photocoagulation in diabetic retinopathy. 51st International Society for Clinical Electrophysiology of Vision, ISCEV International Symposium; 2013 Oct 13-17; Chongqing China. Documenta Ophthalmologica. 2013.
57. Crick MD, Chignell AH, Shilling JS. Argon laser v. xenon arc photocoagulation in proliferative diabetic retinopathy. Transactions of the Ophthalmological Societies of the United Kingdom 1978;98(1):170-1.
58. Doft BH, Blankenship GW. Single versus multiple treatment sessions of argon laser panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 1982;89(7):772-9.
59. Doft BH. The effect of augmentation laser in diabetics with proliferative retinopathy who do not respond to initial pan-retinal photocoagulation. American Academy of Ophthalmology 1991:147.
60. Doft BH, Metz DJ, Kelsey SF. Augmentation laser for proliferative diabetic retinopathy that fails to respond to initial panretinal photocoagulation. Ophthalmology 1992;99(11):1728-34.
61. Dong P, Yang XP. Observation on the curative efficacy of Ahalysantinfarctase laser coagulation in treating diabetic retinopathy. Central Plains Medical Journal 1997;24(8):32-3.
62. Elsner H, Liew SHM, Klatt C, Hamilton P, Marshall J, Pörksen E, et al. Selective-Retina-Therapy (SRT) multicenter clinical trial: 6 month results in patients with diabetic maculopathy. Investigative Ophthalmology and Visual Science 2005;46:ARVO E-abstract 1463.
63. Emi K, Ikeda T, Bando H, Sato S, Morita S, Oyagi T, et al. Efficacy of treatments on vision-related quality of life in patients with diabetic retinopathy. Nippon Ganka Gakkai Zasshi 2009; Vol. 113, issue 11:1092-7.
64. Fankhauser F, Gloor B, Roulier A. Results of the treatment of diabetic retinopathy by photocoagulation using the argon gas laser and the xenon high pressure lamp [Ergebnisse der behandlung der diabetischen retinopathie durch photokoagulation mit dem argon-gaslaser und der xenonhochdrucklampe]. Modern Problems in Ophthalmology 1972;10:558-63.
65. Fankhauser F, Lotmar W, Roulier A. Efficiency comparison of the argon laser and the high-pressure xenon arc lamp in the treatment of diabetic retinopathy by photocoagulation. II. Clinical results [Vergleichende behandlung der diabetischen retinopathie durch photocoagulation mit dem argon-laser und der xenon-hochdrucklampe. II. Klinische ergebnisse]. Graefe's Archive for Clinical and Experimental Ophthalmology 1972;184(2):111-25.
66. Francois J, Cambie E. Argon laser photocoagulation in diabetic retinopathy. A comparative study of three different methods of treatment. Metabolic Ophthalmology, Pediatric and Systemic 1977;1(2):125-30.
67. Gerke E, Bornfeld N, Meyer-Schwickerath G. Importance of the localization of the photocoagulation focus in the therapy of proliferative diabetic retinopathy [Die bedeutung der lokalisation der photokoagulationsherde bei der therapie der proliferativen diabetischen retinopathie]. Fortschritte der Ophthalmologie 1985;82(1):109-11.
68. Haas A, Feigl B, Hanselmayer R, Freigassner P. Panretinal photocoagulation using a micropulsed diode laser in proliferative diabetic retinopathy [Panretinale photokoagulation mit dem mikrogepulsten diodenlaser bei proliferativer diabetischer retinopathie]. Spektrum der Augenheilkunde 1999;13(6):247-50.
69. Hamilton AM, Townsend C, Khoury D, Gould E, Blach RK. Xenon arc and argon laser photocoagulation in the treatment of diabetic disc neovascularization. Part 1. Effect on disc vessels, visual fields, and visual acuity. Transactions of the Ophthalmological Societies of the United Kingdom 1981;101(1):87-92.
70. Ivanisevic M. Photocoagulation of diabetic maculopathy. Acta Medica Croatica 1992;46(2):113-7.
71. Anonymous. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularization. The Krypton Argon Regression Neovascularization Study report number 1. Ophthalmology 1993;100(11):1655-64.
72. Anonymous. Randomized comparison of krypton versus argon scatter photocoagulation for diabetic disc neovascularizion. Lasers and Light in Ophthalmology 1994;6:204.
73. Chew E, Ferris F, Singerman LJ, Brucker A, Murphy R, Mowery R. Clinical results of the Krypton-Argon Regression of Neovascularization Study (KARNS). The Macula Society 1991:40.
74. Singerman LJ, Ferris FL, Chew EY, Murphy R. Krypton Argon Regression of Neovascularization Study: results of a randomized controlled clinical trial. American Academy of Ophthalmology 1992:92.
75. Singerman LJ, Ferris FL, Mowery RP, Brucker AJ, Murphy RP, Lerner BC, et al. Krypton laser for proliferative diabetic retinopathy: the Krypton Argon Regression of Neovascularization Study. Journal of Diabetic Complications 1988;2(4):189-96.
76. Khosla PK, Rao V, Tewari HK, Kumar A. Contrast sensitivity in diabetic retinopathy after panretinal photocoagulation. Ophthalmic Surgery 1994;25(8):516-20.
77. Klemen C, Klemen UM, Prskavec FH, Gnad HD. Follow-up of central diabetic retinal changes following peripheral photocoagulation. Klinische Monatsblatter fur Augenheilkunde 1985;187(5):435-6.
78. Kovacic Z, Ivanisevic M, Karelovic D. The loss of visual field after proliferative diabetic retinopathy treatment with two different techniques of panretinal photocoagulation [Gubitak perifernog vidnog polja nakon terapije proliferacijske dijabeticne retinopatije dvjema razlicitim tehnikama panretinalne fotokoagulacije]. Acta Medica Croatica 2007;61(2):149-52.
79. Kovacic Z, Ivanisevic M, Bojic L, Hrgovic Z, Lesin M, Kurelovic D. Comparing two techniques of panretinal photocoagulation on visual acuity on patients with proliferative diabetic retinopathy. Medical Archives (Sarajevo, Bosnia and Herzegovina) 2012;66(5):321-3.
80. Li XX, Lapp ER, Bornfeld N, Gerke E, Foerster MH. Electroretinography findings in proliferative diabetic retinopathy following argon laser coagulation of the middle and exterior peripheral retina. Fortschritte der Ophthalmologie 1986;83(4):459-61.
81. Liang JC, Fishman GA, Huamonte FU, Anderson RJ. Comparative electroretinograms in argon laser and xenon arc panretinal photocoagulation. British Journal of Ophthalmology 1983;67(8):520-5.
82. Lim MC, Tanimoto SA, Furlani BA, Lum B, Pinto LM, Eliason D, et al. Effect of diabetic retinopathy and panretinal photocoagulation on retinal nerve fiber layer and optic nerve appearance. Archives of Ophthalmology 2009;127(7):857-62.
83. Lopez MD, Velez-Montoya R, Vera-Rodriguez S, Martinez-Castellanos M, Burgos-Vejar O, Gonzalez-Mijares CC, et al. Pattern-acan laser system vs. conventional photocoagulation: changes in macular thickness after treatment. Investigative Ophthalmology and Visual Science 2008:ARVO E-abstract 2768.
84. Muqit MM, Marcellino GR, Gray JC, McLauchlan R, Henson DB, Young LB, et al. Pain responses of Pascal 20 ms multi-spot and 100 ms single-spot panretinal photocoagulation: Manchester Pascal Study, MAPASS report 2. British Journal of Ophthalmology 2010;94(11):1493-8.
85. Muqit MM, Marcellino GR, Henson DB, Young LB, Patton N, Charles SJ, et al. Single-session vs multiple-session pattern scanning laser panretinal photocoagulation in proliferative diabetic retinopathy: The Manchester Pascal Study. Archives of Ophthalmology 2010;128(5):525-33.
86. Muqit MM, Marcellino GR, Henson DB, Young LB, Turner GS, Stanga PE. Pascal panretinal laser ablation and regression analysis in proliferative diabetic retinopathy: Manchester Pascal Study Report 4. Eye 2011;25(11):1447-56.
87. McLean EB. Argon and xenon photocoagulation in the treatment of diabetic retinopathy. Transactions of the Pacific Coast Oto-Ophthalmological Society Annual Meeting 1972;57:183-92.
88. Menchini U, Scialdone A, Pietroni C, Carones F, Brancato R. Argon versus krypton panretinal photocoagulation side effects on the anterior segment. Ophthalmologica 1990;201(2):66-70.
89. Menchini U, Lanzetta P, Soldano F, Ferrari E, Virgili G. Continuous wave Nd:YAG laser photocoagulation in proliferative diabetic retinopathy. British Journal of Ophthalmology 1995;79(7):642-5.
90. Mirkiewicz-Sieradzka B, Romanowska B, Zygulska-Machowa H. Panphotocoagulation in simple and proliferative diabetic retinopathy. Klinika Oczna 1988;90(9):317-9.
91. Mirshahi A, Lashay A, Roozbahani M, Fard MA, Molaie S, Mireshghi M, et al. Pain score of patients undergoing single spot, short pulse laser versus conventional laser for diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 2013;251(4):1103-7.
92. Misra S, Ahn HN, Craig JP, Pradhan M, Patel DV, McGhee CN. Effect of panretinal photocoagulation on corneal sensation and the corneal subbasal nerve plexus in diabetes mellitus. Investigative Ophthalmology and Visual Science 2013;54(7):4485-90.
93. Mody K, Saxena A. Krypton laser--clinical trial and preliminary observations. Indian Journal of Ophthalmology 1983;31 Suppl:1031-7.
94. Muraly P, Limbad P, Srinivasan K, Ramasamy K. Single session of Pascal versus multiple sessions of conventional laser for panretinal photocoagulation in proliferative diabetic retinopathy: a comparative study. Retina 2011;31(7):1359-65.
95. Nagpal M, Marlecha S, Nagpal K. Comparative study of efficacy and of collateral damage of laser burns using single spot argon laser and pattern scan laser. American Academy of Ophthalmology 2008:263.
96. Nagpal M, Marlecha S, Nagpal K. Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. Retina 2010;30(3):452-8.
97. Stanga PE, Muqit MM. Re: Comparison of laser photocoagulation for diabetic retinopathy using 532-nm standard laser versus multispot pattern scan laser. Retina 2010;30(10):1749-50.
98. Neira-Zalentein W, Holopainen JM, Tervo TM, Borrás F, Acosta MC, Belmonte C, et al. Corneal sensitivity in diabetic patients subjected to retinal laser photocoagulation. Investigative Ophthalmology and Visual Science 2011;52(8):6043-9.
99. Okuyama M, Okisaka S, Ito M. Comparative study on frequency-doubled Nd: YAG laser, krypton laser and diode laser photocoagulation for diabetic maculopathy. Journal of Japanese Ophthalmological Society 1995;99(1):87-92.
100. Pahor D. Visual field loss after argon laser panretinal photocoagulation in diabetic retinopathy: Full-versus mild-scatter coagulation. International Ophthalmology 1998;22(5):313-9.
101. Pahor D, Gracner B. Peripheral retinal light sensitivity following panretinal argon laser photocoagulation in diabetic retinopathy [Periphere lichtunterschiedsempfindlichkeit (LUE) der netzhaut nach panretinaler argon laser photokoagulation bei diabetischer retinopathie]. Spektrum der Augenheilkunde 1999;13(4):164-7.
102. Pahor D, Gracner B. Peripheral retinal light sensitivity following panretinal argon laser photocoagulation in diabetic retinopathy [Periphere lichtunterschiedsempfindlichkeit (LUE) der netzhaut nach panretinaler argon laser photokoagulation bei diabetischer retinopathie]. Spektrum der Augenheilkunde 1999;13(5):214-7.
103. Peng ZH, Cheng GM, Wu L. Observation of clinical efficacy of pattern scan laser photocoagulation on diabetic retinopathy. International Eye Science 2013;13(8):1639-41.
104. Perez Montesinos A, Velez-Montoya R, Burgos O, Lopez-Ramos L, Alvarez-Verduzco O, Gonzalez-Mijares C, et al. Pattern scan laser system vs. regular photocoagulation system: changes in contrast sensitivity post treatment in patients with diabetic retinopathy. Investigative Ophthalmology and Visual Science 2008:ARVO E-abstract 3507.
105. Muqit MM, Young LB, McKenzie R, John B, Marcellino GR, Henson DB, et al. Pilot randomised clinical trial of Pascal TargETEd Retinal versus variable fluence PANretinal 20 ms laser in diabetic retinopathy: PETER PAN study. British Journal of Ophthalmology 2013;97(2):220-7.
106. Plumb AP, Swan AV, Chignell AH, Shilling JS. A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy. British Journal of Ophthalmology 1982;66(4):213-8.
107. Salman AG. Pascal laser versus conventional laser for treatment of diabetic retinopathy. Saudi Journal of Ophthalmology 2011;25(2):175-9.
108. Schiodte SN. Changes in pressure pulse amplitudes of normotensive diabetic eyes after panretinal photocoagulation. A long term study with comparison of xenon arc and argon laser. Acta Ophthalmologica 1983;61(5):769-77.
109. Seiberth V, Alexandridis E, Feng W. Retinal function following panretinal laser coagulation in diabetic retinopathy--dependence on the size and density of coagulation spots. Fortschritte der Ophthalmologie 1986;83(4):462-6.
110. Seiberth V, Alexandridis E, Feng W. Function of the diabetic retina after panretinal argon laser coagulation. Graefe's Archive for Clinical and Experimental Ophthalmology 1987;225(6):385-90.
111. Seiberth V, Schatanek S, Alexandridis E. Panretinal photocoagulation in diabetic retinopathy: argon versus dye laser coagulation. Graefe's Archive for Clinical and Experimental Ophthalmology 1993;231(6):318-22.
112. Seymenoglu G, Kayikcioglu O, Baser E, Sami Ilker S. Comparison of pain response of patients undergoing panretinal photocoagulation for proliferati diabetic retinopathy: 532 nm standard laser vs. multispot pattern scan laser. Turk Oftalmoloiji Dergisi 2013;43(4):221-4.
113. Shimura M, Yasuda K, Nakazawa T, Kano T, Ohta S, Tamai M. Quantifying alterations of macular thickness before and after panretinal photocoagulation in patients with severe diabetic retinopathy and good vision. Ophthalmology 2003;110(12):2386-94.
114. Shimura M, Yasuda K, Nakazawa T, Abe T, Shiono T, Iida T, et al. Panretinal photocoagulation induces pro-inflammatory cytokines and macular thickening in high-risk proliferative diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 2009;247(12):1617-24.
115. Stanga PE, Muqit MM. Retinal laser photocoagulation, anaesthesia, and pain responses. Eye 2010;24(8):1415-6.
116. Tewari HK, Ravindranath HM, Kumar A, Verma L. Diode laser scatter photocoagulation in diabetic retinopathy. Annals of Ophthalmology 2000;32(2):110-2.
117. Theodossiadis GP, Boudouri A, Georgopoulos G, Koutsandrea C. Central visual field changes after panretinal photocoagulation in proliferative diabetic retinopathy. Ophthalmologica 1990;201(2):71-8.
118. Townsend C, Bailey J, Kohner E. Xenon arc photocoagulation for the treatment of diabetic maculopathy. Interim report of a multicentre controlled clinical study. British Journal of Ophthalmology 1980;64(6):385-91.
119. Townsend C, Bailey J, Kohner EM. Xenon arc photocoagulation in the treatment of diabetic maculopathy. Transactions of the Ophthalmological Societies of the United Kingdom 1979;99(1):13-6.
120. Uehara M, Tamura N, Kinjo M, Shinzato K, Fukuda M. A prospective study on necessary and sufficient retinal photocoagulation for diabetic retinopathy. Journal of Japanese Ophthalmological Society 1993;97(1):83-9.
121. Vera-Rodriguez SE, Velez-Montoya R, Lopez-Ramos ML, Alvarez-Verduzco O, Martinez-Castellanos MA, Gonzalez-Mijares CC, et al. Pattern scan laser system vs. conventional photocoagulation system: electroretinogram changes after treatment. Investigative Ophthalmology and Visual Science 2008:ARVO E-abstract 2766.
122. Wade EC, Blankenship GW. The effect of short versus long exposure times of argon laser panretinal photocoagulation on proliferative diabetic retinopathy. Graefe's Archive for Clinical and Experimental Ophthalmology 1990;228(3):226-31.
123. Wiznia RA. Photocoagulation of non-proliferative diabetic retinopathy. The Macula Society 1985:104.
124. Wroblewski JJ, Anand R. Macular effects of central versus peripheral scatter laser treatment in proliferative-diabetic retinopathy. Investigative Ophthalmology and Visual Science 1991;32:ARVO E-abstract 1762.
125. Wroblewski J, Anand R, Weakley D. Techniques of panretinal photocoagulation for proliferative diabetic retinopathy. A prospective clinical trial. Investigative Ophthalmology and Visual Science 1992;33:ARVO E-abstract 3357.
126. Zaluski S, Marcil G, Lamer L, Lambert J. Study of the visual field using automated static perimetry following panretinal photocoagulation in the diabetic. Journal Français d'Ophtalmologie 1986;9(5):395-401.
127. Francois J, Cambie E. Retinal photocoagulation (xenon arc and lasers). Annals of Ophthalmology 1971;3(11):1201-8.
128. Gaudric A, Glacet A, Crama F, Coscas G. Intraocular photocoagulation using the argon laser. Bulletin des Societes d'Ophtalmologie de France 1987;87(10):1083-4.
129. Guo Y, Liu Y, Zhang SB. Proliferative diabetic retinopathy observed after laser photocoagulation. International Eye Science 2014;13(11):2333-5.
130. Kaluzny J, Kozlowski JM, Jalkh AE. Photocoagulation in diabetic retinopathy: indications and technics. Klinika Oczna 1985;87(4):154-7.
131. Krill AE, Archer DB, Newell FW, Chishti MI. Photocoagulation in diabetic retinopathy. American Journal of Ophthalmology 1971;72(2):299-321.
132. Leuenberger AE. Light coagulation of diabetic retinopathy. Modern Problems in Ophthalmology 1975;15:307-12.
133. Li XX. ERG in proliferative diabetic retinopathy after photocoagulation. Chinese Journal of Ophthalmology 1987;23(3):140-2.
134. Lund OE. Local treatment (light coagulation) in diabetic retinopathy [Lokalbehandlung (Lichtcoagulation) bei Retinopathia diabetica]. Internist 1971;12(11):475-81.
135. Mella I, De Los Rios MG, Tapia JC, Garcia H, Guzman E. Results of photocoagulation in 111 eyes with diabetic retinopathy [Resultados de la fotocoagulacion en 111 ojos con retinopatia diabetica]. Revista Medica de Chile 1976;104(10):709-12.
136. Mirzabekova KA. Laser coagulation in the treatment of diabetic retinopathy. Vestnik Oftalmologii 2004;120(4):41-4.
137. Okun E. The effectiveness of photocoagulation in the therapy of proliferative diabetic retinopathy (PDR). (A controlled study in 50 patients). Transactions -American Academy of Ophthalmology and Otolaryngology. American Academy of Ophthalmology and Otolaryngology 1968;72:246-52.
138. Pahor D, Gracner B. Changes in central reference level of visual field following argon laser photocoagulation in diabetic retinopathy. Spektrum der Augenheilkunde 1997;11(1):19-21.
139. Palacz O, Sylwestrzak Z, Oszczyk U. Electrophysiologic studies before and after laser panphotocoagulation in diabetic retinopathy. I. Early results [Badania elektrofizjologiczne przed i po panfotokoagulacji laserowej w retinopatii cukrzycowej. I. Wyniki wczesne]. Klinika Oczna 1988;90(9):320-2.
140. Davidson JA, Ciulla TA, McGill JB, Kles KA, Anderson PW. How the diabetic eye loses vision. Endocrine 2007;32(1):107-16.
141. Anonymous. Photocoagulation treatment of proliferative diabetic retinopathy: relationship of adverse treatment effects to retinopathy severity. Diabetic retinopathy study report no. 5. Developments in Ophthalmology 1981;2:248-61.
142. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
143. Grover D, Li T, Chong CC. Intravitreal steroids for macular edema in diabetes. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD005656.pub2]
144. Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. Journal of Clinical Epidemiology 2011;64(4):383-94.
145. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002;21(11):1539-58.
146. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
147. Jorge EC, Jorge EN, El Dib R. Laser photocoagulation for diabetic macular oedema. Cochrane Database of Systematic Reviews 2013, Issue 11. [DOI: 10.1002/14651858.CD010859]
148. Martinez-Zapata MJ, Martí-Carvajal AJ, Solà I, Pijoán JI, Buil-Calvo JA, Cordero JA, Evans JR. Anti-vascular endothelial growth factor for proliferative diabetic retinopathy. Cochrane Database of Systematic Reviews 2014, Issue 11. [DOI: 10.1002/14651858.CD008721.pub2]
149. Ockrim Z, Yorston D. Managing diabetic retinopathy. BMJ 2010;341:c5400.
150. Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. British Journal of Ophthalmology 2012;96(5):614-8.
151. Royal College of Ophthalmologists. Diabetic Retinopathy Guidelines 2012. www.rcophth.ac.uk/page.asp?section=451 (accessed 14 March 2014).
152. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
153. Stefansson E. The therapeutic effects of retinal laser treatment and vitrectomy. A theory based on oxygen and vascular physiology. Acta Ophthalmologica Scandinavica 2001;79(5):435-40.
154. Virgili G, Parravano M, Menchini F, Brunetti M. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. Cochrane Database of Systematic Reviews 2012, Issue 12. [DOI: 10.1002/14651858.CD007419.pub3]
155. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27(5):1047-53.
156. Evans JR, Fau C, Virgili G. Laser photocoagulation for diabetic retinopathy. Cochrane Database of Systematic Reviews 2014, Issue 8. [DOI: 10.1002/14651858.CD011234]